The effect of different doses of vitamin D on the prognosis of patients undergoing carpal tunnel syndrome surgery.
Boston functional scale
Boston severity scale
carpal tunnel syndrome
pain
vitamin D
Journal
Journal of family medicine and primary care
ISSN: 2249-4863
Titre abrégé: J Family Med Prim Care
Pays: India
ID NLM: 101610082
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
31
01
2022
revised:
24
04
2022
accepted:
17
05
2022
medline:
31
3
2023
entrez:
30
3
2023
pubmed:
31
3
2023
Statut:
ppublish
Résumé
Vitamin D accelerates myelin repair and recovery after nerve damage. This study aimed to evaluate the effect of vitamin D on the prognosis of patients with carpal tunnel syndrome (CTS). A randomized clinical trial was conducted in the orthopedic ward of Golestan and Imam Khomeini hospitals in Ahvaz for 2 years (from October 2018 to October 2020). Patients were divided into three groups: the first group received 1,000 units of vitamin D daily, the second group received 4,000 units of vitamin D per week for the first 4-6 weeks and then 2,000 units per month, and the third group received no vitamin D supplementation. The results were compared before and after 6 months between the study groups. A total of 105 patients were included in the study, who were divided into three groups. The mean age of the patients was 39.24 ± 7.01 years (25-52 years). The mean level of the vitamin D in the control group was 25.40 ± 8.37 ng/mL, the group receiving 1,000 units/day was 26.71 ± 8.70 ng/mL, and the group receiving 50,000 units per week was 26.17 ± 8.63 ng/mL. The mean values of preoperative pain intensity, symptom severity, and functional status were almost the same in the three groups. These values were reduced after surgery in the two groups receiving the drug compared to the control group. The findings of the study showed that the administration of vitamin D supplementation in patients with CTS can significantly improve the postoperative symptoms of patients who underwent tendon release surgery and further improve the severity of symptoms and dysfunction of patients.
Sections du résumé
Background and Objective
UNASSIGNED
Vitamin D accelerates myelin repair and recovery after nerve damage. This study aimed to evaluate the effect of vitamin D on the prognosis of patients with carpal tunnel syndrome (CTS).
Methods
UNASSIGNED
A randomized clinical trial was conducted in the orthopedic ward of Golestan and Imam Khomeini hospitals in Ahvaz for 2 years (from October 2018 to October 2020). Patients were divided into three groups: the first group received 1,000 units of vitamin D daily, the second group received 4,000 units of vitamin D per week for the first 4-6 weeks and then 2,000 units per month, and the third group received no vitamin D supplementation. The results were compared before and after 6 months between the study groups.
Results
UNASSIGNED
A total of 105 patients were included in the study, who were divided into three groups. The mean age of the patients was 39.24 ± 7.01 years (25-52 years). The mean level of the vitamin D in the control group was 25.40 ± 8.37 ng/mL, the group receiving 1,000 units/day was 26.71 ± 8.70 ng/mL, and the group receiving 50,000 units per week was 26.17 ± 8.63 ng/mL. The mean values of preoperative pain intensity, symptom severity, and functional status were almost the same in the three groups. These values were reduced after surgery in the two groups receiving the drug compared to the control group.
Conclusions
UNASSIGNED
The findings of the study showed that the administration of vitamin D supplementation in patients with CTS can significantly improve the postoperative symptoms of patients who underwent tendon release surgery and further improve the severity of symptoms and dysfunction of patients.
Identifiants
pubmed: 36993071
doi: 10.4103/jfmpc.jfmpc_252_22
pii: JFMPC-11-6837
pmc: PMC10041256
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6837-6842Informations de copyright
Copyright: © 2022 Journal of Family Medicine and Primary Care.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Nephrology (Carlton). 2004 Oct;9(5):262-4
pubmed: 15504137
J Neurosci Res. 2006 May 15;83(7):1179-89
pubmed: 16521124
Am J Clin Nutr. 2004 Dec;80(6 Suppl):1678S-88S
pubmed: 15585788
Arch Orthop Trauma Surg. 2004 May;124(4):278-80
pubmed: 14735303
Eur Radiol. 2009 Jan;19(1):144-6
pubmed: 18677489
Turk Neurosurg. 2010 Jul;20(3):353-7
pubmed: 20669109
Arq Neuropsiquiatr. 2004 Sep;62(3A):596-9
pubmed: 15334215
Radiology. 2015 Mar;274(3):821-9
pubmed: 25329764
J Nutr. 2005 Nov;135(11):2739S-48S
pubmed: 16251641
Clin Neurophysiol. 2002 Jan;113(1):64-70
pubmed: 11801426
Reg Anesth Pain Med. 2008 Jul-Aug;33(4):363-8
pubmed: 18675750
Am J Clin Nutr. 2004 Mar;79(3):362-71
pubmed: 14985208
J Hand Surg Am. 1995 Sep;20(5):848-54
pubmed: 8522755
J Hand Surg Am. 2019 Aug;44(8):649-654
pubmed: 31047743
J Bone Metab. 2014 Nov;21(4):257-62
pubmed: 25489574
Open Orthop J. 2010 Aug 27;4:234-6
pubmed: 21249165
Arch Orthop Trauma Surg. 2008 Feb;128(2):125-7
pubmed: 18038143
Egypt J Neurol Psychiatr Neurosurg. 2018;54(1):14
pubmed: 29780234
Ultrasound Med Biol. 2015 Nov;41(11):2899-905
pubmed: 26304500
Am J Physiol Cell Physiol. 2013 Jun 1;304(11):C1027-39
pubmed: 23364265
BMJ Open Diabetes Res Care. 2016 Feb 10;4(1):e000148
pubmed: 27026808
Calcif Tissue Int. 2013 Feb;92(2):151-62
pubmed: 22968766
Endocr Pract. 2017 May;23(5):605-613
pubmed: 28095044
Neurol Sci. 2016 Jul;37(7):1055-61
pubmed: 26939675
J Hand Surg Br. 2006 Dec;31(6):683-6
pubmed: 17046117
Clin J Sport Med. 2003 Jan;13(1):11-5
pubmed: 12544158
AJR Am J Roentgenol. 2009 Aug;193(2):W134-8
pubmed: 19620415
Muscle Nerve. 2007 Aug;36(2):167-71
pubmed: 17534984
J Am Acad Orthop Surg. 2003 May-Jun;11(3):192-200
pubmed: 12828449
Int J Burns Trauma. 2021 Oct 15;11(5):385-390
pubmed: 34858718
Ann Intern Med. 2012 Mar 20;156(6):425-37
pubmed: 22431675
Connect Tissue Res. 2013;54(1):76-81
pubmed: 23186247